1. A Cost-Effectiveness Analysis of an Adjuvanted Subunit Vaccine for the Prevention of Herpes Zoster and Post-Herpetic Neuralgia. (4th October 2017) Authors: Carpenter, Christopher; Aljassem, Annas; Stassinopoulos, Jerry; Pisacreta, Giovanni; Hutton, David Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Cost-effectiveness Analysis of an Adjuvanted Subunit Vaccine for the Prevention of Herpes Zoster and Post-herpetic Neuralgia. (8th May 2019) Authors: Carpenter, Christopher F; Aljassem, Annas; Stassinopoulos, Jerry; Pisacreta, Giovanni; Hutton, David Journal: Open forum infectious diseases Issue: Volume 6:Number 7(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Abstract 03: The Global Macroeconomic Burden of Breast Cancer. (April 2018) Authors: Ranganathan, Kavitha; Singh, Puneet; Wilkins, Edwin G.; Hamill, Jennifer B.; Aliu, Oluseyi; Newman, Lisa; Hutton, David; Momoh, Adeyiza O. Journal: Plastic and reconstructive surgery Issue: Volume 6(2018)Supplement 4S Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Age-related Aortic Stiffness Can Be Transferred and Ameliorated via Fecal Microbiota Transplant in Mice. (17th December 2021) Authors: Greenberg, Nathan; VanDongen, Nicholas; Gioscia-Ryan, Rachel; Casso, Abigail; Hutton, David; Clayton, Zachary; Seals, Douglas; Brunt, Vienna Journal: Innovation in aging Issue: Volume 5(2021)Supplement 1 Page Start: 829 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Age-related Aortic Stiffness Can Be Transferred and Ameliorated via Fecal Microbiota Transplant in Mice. (17th December 2021) Authors: Greenberg, Nathan; VanDongen, Nicholas; Gioscia-Ryan, Rachel; Casso, Abigail; Hutton, David; Clayton, Zachary; Seals, Douglas; Brunt, Vienna Journal: Innovation in aging Issue: Volume 5(2021)Supplement 1 Page Start: 823 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cost-effectiveness analysis of first-line pembrolizumab treatment for PD-L1 positive, non-small cell lung cancer in China. (3rd April 2019) Authors: Liao, Weiting; Huang, Jiaxing; Hutton, David; Li, Qiu Journal: Journal of medical economics Issue: Volume 22:Number 4(2019) Page Start: 344 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cost-Effectiveness of 1-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States. (6th May 2021) Authors: Toy, Mehlika; Hutton, David; Harris, Aaron M; Nelson, Noele; Salomon, Joshua A; So, Samuel Journal: Clinical infectious diseases Issue: Volume 74:Number 2(2022) Page Start: 210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Gaps and Disparities in Chronic Hepatitis B Monitoring and Treatment in the United States, 2016-2019. Issue 4 (3rd April 2023) Authors: Pham, Thi T. Hang; Toy, Mehlika; Hutton, David; Thompson, William; Conners, Erin E.; Nelson, Noele P.; Salomon, Joshua A.; So, Samuel Journal: Medical care Issue: Volume 61:Issue 4(2023)supplement 1 Page Start: 247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Letter to the editor: Importance of universal screening for chronic hepatitis B infection in adults in the United States. Issue 4 (8th January 2022) Authors: Cohen, Chari; Moraras, Kate; Jackson, Michalea; Kamischke, Maureen; Gish, Robert G.; Brosgart, Carol L.; Toy, Mehlika; Hutton, David; Block, Timothy M.; Wang, Su; So, Samuel Journal: Hepatology Issue: Volume 75:Issue 4(2022) Page Start: 1062 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OPTIMAL and ENSURE trials-based combined cost-effectiveness analysis of erlotinib versus chemotherapy for the first-line treatment of Asian patients with non-squamous non-small-cell lung cancer. Issue 4 (13th April 2018) Authors: Wen, Feng; Zheng, Hanrui; Zhang, Pengfei; Hutton, David; Li, Qiu Journal: BMJ open Issue: Volume 8:Issue 4(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗